ArticleJournal of neurology2020

Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223.

Brian Steingo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.